The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.

Source:http://linkedlifedata.com/resource/pubmed/id/12209314

Download in:

View as

General Info

PMID
12209314